AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Peppermint Oil Trial Suggests an Unexpected, Low-Cost Path to Blood Pressure Control
A new clinical trial reported that peppermint oil may lower blood pressure, adding to the long list of natural products being explored for measurable cardiovascular effects. While the finding is preliminary, it could attract attention because it points to a simple, inexpensive intervention rather than a high-tech device or drug.
Orchestra BioMed Gets Another FDA Breakthrough Device Tag for AVIM Therapy
The FDA granted Orchestra BioMed an additional Breakthrough Device Designation for AVIM therapy, extending regulatory momentum for the cardiovascular technology. The designation may help streamline development and communication with regulators, but it does not substitute for clinical proof.
Abbott Wins AI Imaging Clearance in the U.S. and Europe, Deepening Its Cardiovascular Platform
Abbott has secured FDA clearance and CE mark approval for an AI-powered imaging platform, adding another regulatory win in cardiovascular care. The move underscores how device makers are pairing imaging hardware with software to create more differentiated, data-rich products. The significance is not just approval, but market positioning: AI is becoming a core feature of cardiovascular workflows rather than an experimental add-on.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.